We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration

News   Nov 06, 2012

 
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
 
 
 

RELATED ARTICLES

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

Real-time Flu Tracker Website Launched

News

Pathologists have developed a real-time website to track flu cases across eight hospitals, just in time to assist physicians, the CDC and patients for the fall 2018 flu season.

READ MORE

High-throughput Platform Enables Activity Mapping of Emerging Cancer Drug Targets

News

A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE